These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 32677984)
1. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984 [TBL] [Abstract][Full Text] [Related]
2. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling. Pei J; Zhang S; Yang X; Han C; Pan Y; Li J; Wang Z; Sun C; Zhang J RNA Biol; 2021 Oct; 18(sup1):287-302. PubMed ID: 34130584 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2. Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis. Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993 [TBL] [Abstract][Full Text] [Related]
6. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway. Li G; Yang J; Chong T; Huang Y; Liu Y; Li H Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740 [TBL] [Abstract][Full Text] [Related]
7. lncRNA SNHG11 Promotes Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway and Oncogenic Autophagy. Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M Mol Ther; 2021 Mar; 29(3):1258-1278. PubMed ID: 33068778 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265 [TBL] [Abstract][Full Text] [Related]
10. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression. Huo W; Tan D; Chen Q Nephron; 2020; 144(8):388-399. PubMed ID: 32570259 [TBL] [Abstract][Full Text] [Related]
11. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158 [TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis. Rui X; Wang L; Pan H; Gu T; Shao S; Leng J J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis. Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578 [TBL] [Abstract][Full Text] [Related]
14. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1. Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA. Zhan Y; Chen Z; Li Y; He A; He S; Gong Y; Li X; Zhou L J Exp Clin Cancer Res; 2018 Nov; 37(1):273. PubMed ID: 30419948 [TBL] [Abstract][Full Text] [Related]
16. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro. Tang Y; Yang P; Zhu Y; Su Y Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related]
18. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036 [TBL] [Abstract][Full Text] [Related]
19. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1. Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis. Li C; Zhang J; Zhou Y; Li B Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]